| 000 | 01038 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516141503.0 | ||
| 264 | 0 | _c20130507 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1535-4970 | ||
| 024 | 7 |
_a10.1164/rccm.201301-0133ED _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVeit, Florian | |
| 245 | 0 | 0 |
_aAngiotensin-converting enzyme 2 activation for treatment of pulmonary hypertension. _h[electronic resource] |
| 260 |
_bAmerican journal of respiratory and critical care medicine _cMar 2013 |
||
| 300 |
_a569-71 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Comment | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDiminazene _xanalogs & derivatives |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xprevention & control |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aTrypanocidal Agents _xpharmacology |
| 700 | 1 | _aWeissmann, Norbert | |
| 773 | 0 |
_tAmerican journal of respiratory and critical care medicine _gvol. 187 _gno. 6 _gp. 569-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1164/rccm.201301-0133ED _zAvailable from publisher's website |
| 999 |
_c22591298 _d22591298 |
||